Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
34.8M
-
Number of holders
-
163
-
Total 13F shares, excl. options
-
34.2M
-
Shares change
-
+96.9K
-
Total reported value, excl. options
-
$2.26B
-
Value change
-
+$16.1M
-
Put/Call ratio
-
0.25
-
Number of buys
-
84
-
Number of sells
-
-54
-
Price
-
$66.08
Significant Holders of Disc Medicine, Inc. - COMMON STOCK (IRON) as of Q3 2025
181 filings reported holding IRON - Disc Medicine, Inc. - COMMON STOCK as of Q3 2025.
Disc Medicine, Inc. - COMMON STOCK (IRON) has 163 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 34.2M shares
of 34.8M outstanding shares and own 98.2% of the company stock.
Largest 10 shareholders include FMR LLC (4.94M shares), Atlas Venture Life Science Advisors, LLC (2.14M shares), BlackRock, Inc. (2.02M shares), RA CAPITAL MANAGEMENT, L.P. (1.58M shares), VANGUARD GROUP INC (1.45M shares), Frazier Life Sciences Management, L.P. (1.44M shares), ORBIMED ADVISORS LLC (1.42M shares), WELLINGTON MANAGEMENT GROUP LLP (1.41M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.33M shares), and STATE STREET CORP (1.05M shares).
This table shows the top 163 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.